EQS-News: KPT and Zur Rose are launching an innovative model for basic insurance
EQS Group-News: Zur Rose Group AG / Key word(s): Product Launch
KPT and Zur Rose are launching an innovative model for basic insurance
29.09.2017 / 07:00
--------------------------------------------------------------------------------
Frauenfeld, 29 September 2017
Press release
Purchasing drugs from Zur Rose
KPT and Zur Rose are launching an innovative model for basic insurance
The mail-order pharmacy and wholesale supplier to medical doctors Zur Rose is
marketing an innovative basic insurance model in cooperation with the health
insurance company KPT: For a premium discount of up to 20%, the insured parties
sign an obligation to contact a telemedicine consulting service before utilising
medical services. They obtain prescription drugs exclusively from an attending
doctor or fromZur Rose- by mail or in the Zur Rose pharmacy shops. Together, the
two companies want to make a contribution to saving costs in the medicines
sector.
Parties insured under the new KPTwin.easy model will consult the telemedicine
consulting centre Medi24 before utilising medical services. The experts at the
consulting centre will point out the clinical pathway after talking to the
insured party and refer the patient to a general physician or specialist if
required.
Purchase of drugs through Zur Rose and generics substitution
If drugs are prescribed, the insured parties promise to purchase the medicines
exclusively from Zur Rose - through the mail-order channel or from the Zur Rose
pharmacy shops. Cases in which the medication needs to be taken urgently are
excluded from this regulation. The parties insured under KPTwin.easy also
declare their agreement to prescribed original preparations being replaced by
generics insofar as these are cheaper and there are no objections for medical
reasons.
Contribution to reducing health costs
Purchasing of drugs by mail order is a response to customers' needs. It saves
time because there is no need to visit the pharmacy and it is inexpensive:
Prescription drugs are 12% cheaper at Zur Rose on average than in other
pharmacies because the company grants discounts and does not charge for
medication checking and patient dossier. The CEO of the Zur Rose Group, Walter
Oberhänsli, is convinced: "With the new model, we make a contribution to
lowering health costs and at the same time offer the insured parties an
extremely reliable, inexpensive and attractive drugs supply."
Contact:
Lisa Lüthi, Head of Corporate Communications
e-mail: lisa.luethi@zurrose.com, telephone: +41 52 724 08 14
Zur Rose
Zur Rose, a subsidiary of the Swiss Zur Rose Group AG, is a mail-order pharmacy
and a wholesale supplier to medical doctors, as well as a service provider in
the health sector in Switzerland and Germany. Through its business model, it
helps to ensure safe, reliable and high-quality pharmaceutical care, The Zur
Rose Group is Europe's leading mail-order pharmacy. More information can be
found at zurrosegroup.com and zurrose.ch.
--------------------------------------------------------------------------------
End of Corporate News
--------------------------------------------------------------------------------
Language: English
Company: Zur Rose Group AG
Walzmühlestrasse 60
8500 Frauenfeld
Switzerland
Phone: +41 52 724 08 14
Internet: www.zurrosegroup.com
ISIN: CH0199729366, CH0042615283
Listed: SIX Swiss Exchange
End of News EQS Group News Service
--------------------------------------------------------------------------------
612293 29.09.2017
EQS Group-News: Zur Rose Group AG / Key word(s): Half Year Results Half-Year Results 2017: Zur Rose Group continues on growth trajectory 23.08.2017 / 07:00 603307 23.08.2017 ...
EQS Group-News: Zur Rose Group AG / Key word(s): Alliance Strategic collaboration between Zur Rose and Medbase: Combination of medical and pharmaceutical competence and exclusive supply of drugs to Medbase Centres 11.07.2017 / 07:00 590775 11.07.2017 ...
plus
Ces informations peuvent également vous intéresser
Ces informations peuvent également vous intéresser